Hydrochlorothiazide Tablet
Product Images NDC 43063-747

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydrochlorothiazide (NDC 43063-747). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063747 Label (43063747)

This is a warning label for a medication containing Hydrochlorothiazide with three different versions of 100 tablets each. It advises to keep out of the reach of children and to call a doctor in case of side effects, as well as reports to the FDA. The tablets must be taken a certain number of times a day. The label includes different manufacturing information such as expirations dates and lot numbers. There is also mention of specific organoleptic markings on the tablets.*

FDA Label Image

Structure (Hydrochlorothiazide Str)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.